(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Clinical trial NCT05208047 · RECRUITING
Trial details
- NCT number
- NCT05208047
- Sponsor
- Cogent Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2025-09-30
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.